Modular Approach to Therapy for Anxiety, Depression, Trauma, or Conduct Problems in outpatient child and adolescent mental health services in New Zealand: study protocol for a randomized controlled trial by Lucassen, Mathijs F. G. et al.
Modular Approach to Therapy for Anxiety,
Depression, Trauma, or Conduct Problems
in outpatient child and adolescent mental
health services in New Zealand: study
protocol for a randomized controlled trial
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Lucassen, M. F. G., K. Stasiak, S. Crengle, J. R. Weisz, C. M. A.
Frampton, S. K. Bearman, A. M. Ugueto, et al. 2015. “Modular
Approach to Therapy for Anxiety, Depression, Trauma, or Conduct
Problems in outpatient child and adolescent mental health services
in New Zealand: study protocol for a randomized controlled
trial.” Trials 16 (1): 457. doi:10.1186/s13063-015-0982-9. http://
dx.doi.org/10.1186/s13063-015-0982-9.
Published Version doi:10.1186/s13063-015-0982-9
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:23474057
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
STUDY PROTOCOL Open Access
Modular Approach to Therapy for Anxiety,
Depression, Trauma, or Conduct Problems
in outpatient child and adolescent mental
health services in New Zealand: study
protocol for a randomized controlled trial
Mathijs F. G. Lucassen1,2, Karolina Stasiak2*, Sue Crengle3, John R. Weisz4, Christopher M. A. Frampton5,
Sarah Kate Bearman6, Ana M. Ugueto7, Jennifer Herren8, Ainsleigh Cribb-Su’a9, Monique Faleafa10,
Denise Kingi-’Ulu’ave10, Jik Loy11, Rebecca M. Scott2, Morgyn Hartdegen2 and Sally N. Merry2
Abstract
Background: Mental health disorders are common and disabling for young people because of the potential to disrupt
key developmental tasks. Implementation of evidence-based psychosocial therapies in New Zealand is limited, owing to
the inaccessibility, length, and cost of training in these therapies. Furthermore, most therapies address one problem area
at a time, although comorbidity and changing clinical needs commonly occur in practice. A more flexible approach is
needed. The Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct Problems
(MATCH-ADTC) is designed to overcome these challenges; it provides a range of treatment modules addressing
different problems, within a single training program. A clinical trial of MATCH-ADTC in the USA showed that
MATCH-ADTC outperformed usual care and standard evidence-based treatment on several clinical measures. We
aim to replicate these findings and evaluate the impact of providing training and supervision in MATCH-ADTC to: (1)
improve clinical outcomes for youth attending mental health services; (2) increase the amount of evidence-based
therapy content; (3) increase the efficiency of service delivery.
Methods: This is an assessor-blinded multi-site effectiveness randomized controlled trial. Randomization occurs at two
levels: (1) clinicians (≥60) are randomized to intervention or usual care; (2) youth participants (7–14 years old) accepted
for treatment in child and adolescent mental health services (with a primary disorder that includes anxiety, depression,
trauma-related symptoms, or disruptive behavior) are randomly allocated to receive MATCH-ADTC or usual care. Youth
participants are recruited from ‘mainstream’, Māori-specific, and Pacific-specific child and adolescent mental
health services. We originally planned to recruit 400 youth participants, but this has been revised to 200
participants. Centralized computer randomization ensures allocation concealment. The primary outcome measures are:
(i) the difference in trajectory of change of clinical severity between groups (using the parent-rated Brief Problem
Monitor); (ii) clinicians’ use of evidence-based treatment procedures during therapy sessions; (iii) total time spent by
clinicians delivering therapy.
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Discussion: If MATCH-ADTC demonstrates effectiveness it could offer a practical efficient method to increase access to
evidence-based therapies, and improve outcomes for youth attending secondary care services.
Trial registration: Australian and New Zealand Clinical Trials Registry ACTRN12614000297628.
Keywords: adolescent, anxiety, child, conduct problems, depression, disruptive behavioral disorder, effectiveness,
evidence-based treatments, post-traumatic stress disorder, randomized controlled trial
Background
Mental health problems are common in children and ad-
olescents (youth) and the impact is considerable [1–5],
with an estimated 50 % of all adult mental health disor-
ders having an onset in adolescence [6]. A number of
evidence-based therapies exist for the most common
youth mental health problems, namely anxiety, depres-
sion, trauma-related symptoms, and disruptive behavior
[1]. The Ministry of Health in New Zealand has repeat-
edly asserted the need for evidence-based treatments in
mental health [7–9], including in child and adolescent
mental health services [9]. There is evidence for the ef-
fectiveness of cognitive behavioral therapy for anxiety,
depression, and trauma-related symptoms, while behav-
ioral parent training is the treatment of choice for dis-
ruptive behavior [10–13]. Although these therapies have
been shown to be effective in research settings, they are
challenging to implement in clinical practice [14, 15].
For instance, most traditional evidence-based therapies
focus on one disorder (or a small cluster of related disor-
ders), making it difficult for clinicians to address hetero-
geneous caseloads, client comorbidities, and changes in
clinical presentation during therapy [16]; training for
each single-focus therapy can be time consuming and
costly; and research participants in randomized con-
trolled trials are typically treated for one disorder
(whereas in clinical practice comorbidity is common).
New Zealand’s Child and Adolescent Mental Health
Services (CAMHS) provide secondary level services for
the 3–5 % of those with the most severe mental health
problems aged 0–19 years [17]. The two largest profes-
sional groups employed in these services are nurses and
social workers [18]; however, their pre-registration
courses do not include training in psychotherapies spe-
cifically for youth [19]. Therefore, most learning occurs
‘on the job’. Furthermore, for clinicians to effectively
treat a diverse caseload, they would need to train in mul-
tiple therapies, which is expensive and takes several
years. For example, training in cognitive behavioral ther-
apy is available in New Zealand in a one-year postgradu-
ate course, which can be accessed by up to 12 clinicians
per year. Accredited training in ‘Incredible Years’ (a form
of evidence-based parent management training [20])
takes a year to complete and can be accessed by about
35 clinicians per year. Little training is available outside
these courses and what exists will reach only a small mi-
nority of the approximately 1,000 full-time equivalent
CAMHS clinicians in New Zealand [18]. The extent to
which evidence-based therapies are currently used in
CAMHS is not known, but based on clinicians’ access to
training, and from overseas research [21–23], it is likely
to vary across services and be limited by staff members’
past training, and may not be acceptable or effective for
Māori (the indigenous people of New Zealand) or Pacific
(people from the Pacific region) populations. Moreover,
to meet the projected doubling of the demand on mental
health services by 2020, treatment needs to be delivered
more effectively and efficiently [24].
The Modular Approach to Therapy for Children with
Anxiety, Depression, Trauma, or Conduct Problems
(MATCH-ADTC) is a treatment system designed to
work in day-to-day practice across a range of clinical
problems [25]. MATCH-ADTC was developed following
a number of meta-analyses of therapies with the best
evidence of effectiveness [15, 26, 27] and following
efforts to identify frequently used common elements of
evidence-based practices for children and adolescents
[28]. MATCH-ADTC was specifically designed to com-
bine common elements of treatments for anxiety, de-
pression, trauma-related symptoms, and disruptive
behavior in one protocol, cater for comorbidity, and pro-
vide an opportunity to address fluctuations in presenting
symptoms that might emerge during therapy [25, 29].
MATCH-ADTC comprises modules (i.e., specific prac-
tice elements) that can be organized in a flexible man-
ner. Clinicians are guided by a MATCH-ADTC expert
and an evidence-based algorithm to tailor treatment to
each youth’s characteristics and needs. Youths and their
families are also given an integral role in defining the
goals of therapy. Furthermore, clinicians use a web-
based system to monitor youths’ progress and adapt
therapy until a problem is resolved. MATCH-ADTC has
been evaluated in a randomized controlled trial (n = 174)
comparing it against standard (single-focus) evidence-
based therapies and usual care in the USA. The results
showed that MATCH-ADTC was significantly more ef-
fective than standard evidence-based therapies and usual
care, with effect sizes of 0.59–0.71 on primary outcome
variables [30]. Furthermore, superiority relative to usual
care was maintained in two-year follow-up analyses [31].
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Our objective is to improve the overall quality of care
received by youth attending CAMHS in New Zealand,
by demonstrating improved clinical outcomes, increased
efficiency of services, and increased delivery of evidence-
based therapy. We have used Donabedian’s framework
of structure, process, and outcome [32] to determine the
potential impact of delivering MATCH-ADTC in New
Zealand. In this study, our focus is on outcomes and
process. We designed this trial to assess the effectiveness
of MATCH-ADTC in the New Zealand context and we
aimed in particular to investigate the acceptability and
effectiveness for Māori and Pacific people. New Zealand
has a growing Māori and Pacific population [33, 34],
who are at increased risk of mental health problems
[35–40], yet seldom specifically included in randomized
controlled trials. In New Zealand, mental health services
are delivered through ‘mainstream’ services. In some areas
with large Māori and Pacific communities, there are spe-
cialized Kaupapa Māori and Pacific clinics (services that
use delivery frameworks that are based on Māori or
Pacific philosophies, values, and cultural practices).
This trial will contribute to the international literature
by: (a) testing the effectiveness of MATCH-ADTC in
publicly funded mental health services (a healthcare de-
livery model that is different from that used in the USA);
and (b) providing information about the effectiveness of
MATCH-ADTC across different ethnic groups.
Primary hypotheses
We hypothesize that training CAMHS clinicians in
MATCH-ADTC compared with usual care will:
i. Improve clinical outcomes for children and
adolescents accessing CAMHS (outcomes); we will
determine this by comparing the trajectories of
change in clinical severity for the MATCH-ADTC
and usual care groups (i.e., determining which group
improves more quickly).
ii. Increase the delivery of evidence-based therapy
(process); this will be measured by assessing the
evidence-based content of recorded therapy sessions.
iii. Yield equal or better efficiency of service delivery
(process); this will be measured by clinician time (in
minutes) to deliver therapy, and duration (in weeks)
of contact with the service by children or
adolescents, and their families.
Methods
Design
This study is a multi-site effectiveness randomized con-
trolled trial comparing MATCH-ADTC with usual care
[41]. Prior to randomization, written informed consent is
obtained from each participant. Randomization is imple-
mented on two levels: first, randomization of participating
clinicians, then randomization of youth participants. For
the randomization of clinicians, all clinicians from partici-
pating services were invited to participate and provide writ-
ten informed consent. Consenting clinicians were block
randomized (by service or team) in a 1:1 ratio to MATCH-
ADTC or usual care. The block size varied across sites, de-
pending on the number of individual clinicians recruited
from each site. Clinicians were stratified on the basis of pre-
vious training in evidence-based therapies (i.e., those with
versus those without training in cognitive behavioral ther-
apy or behavioral parent training). Clinicians randomized
to MATCH-ADTC received training in MATCH-ADTC at
the beginning of the study prior to the recruitment of youth
participants. Those randomized to usual care will receive
training at the end of the study (once all follow-up data
have been collected). Randomization of youth participants
occurs after a clinician-administered eligibility check
and once written consent has been obtained. Youth
participants are then randomized in a 1:1 ratio to re-
ceive MATCH-ADTC or usual care, with participants
stratified by sex and ethnicity (Māori, Pacific, or
‘other’). Web-based randomization procedures are
used to determine treatment allocation. Data from all
participants will be included in data analysis, irre-
spective of whether or not all assessments have been
completed.
Changes to design during the trial
Two changes to the protocol were made during the
course of the study.
1. As recruitment was lower than planned, particularly
for Māori and Pacific clinicians and participants, it
became clear that we would not have sufficient
numbers to allow for useful statistical analysis by
ethnicity. As a consequence we have reduced the
number of planned analyses by ethnicity and adjusted
our sample size accordingly. More details are provided
in the ‘Sample size’ section. However, we plan to
augment the data we will have on the use of MATCH-
ADTC for these two populations with a qualitative
study of the acceptability of MATCH-ADTC to Māori
and Pacific clinicians, participants, and their families.
2. At the request of the Health Research Council’s
independent data monitoring committee, who are
overseeing the conduct and safety of the trial, we
added to the data collection on serious adverse events
by collecting information from parents at the three
month follow-up interview on ‘moderate’ adverse
events. More details on this are given below.
Ethics approval
Approval has been received from New Zealand’s Health
and Disability Ethics Committee (13/CEN/97).
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Setting
This study is being conducted in ten outpatient CAMHS
clinics from four provinces in New Zealand (Northland,
Auckland, Waikato, and Wellington).
Participants
Participants are youths and their parents (or guardians),
referred to CAMHS for assessment and treatment. In-
take clinicians identify potential participants during their
standard initial assessment. One self-nominated parent
completes the parent-rated assessments.
Inclusion criteria
Participants are eligible if:
 They are newly referred to, and accepted for treatment
in, CAMHS with a primary disorder that includes
anxiety, depression, trauma-related symptoms, or
disruptive behavior;
 They are 7 to 14 years of age on the date of consent;
 They provide written consent (or verbal assent) and
have written parental consent; and,
 They and their parents speak English.
Exclusion criteria
Participants are ineligible if:
 They are currently receiving other psychosocial
treatment for their disorder within or outside
CAMHS;
 They have a primary disorder of psychosis,
intellectual disability, attention deficit-hyperactivity
disorder (where the primary reason for referral is in-
attention or over-activity), autism, or an eating
disorder;
 They are acutely suicidal; or,
 They have a sibling who has previously been
recruited into the study.
Withdrawal criteria
Participants (youth and their parents, or study clini-
cians) can withdraw from the study at any time.
Those participants who remain in the study but have
dropped out of treatment are followed up wherever
possible. Where a clinician withdraws from the study,
a clinician from the same treatment arm will continue to
provide the treatment allocated (i.e., either MATCH-
ADTC or usual care).
Intervention
Intervention (MATCH-ADTC)
MATCH-ADTC consists of a manual, a training pack-
age, and a monitoring and feedback system (the eMoni-
tor in this study). Clinicians participated in an initial five
day training of block teaching, as well as weekly small
group telephone or Skype consultation sessions, led
by an accredited MATCH-ADTC expert to support
ongoing fidelity to the model. MATCH-ADTC com-
prises 33 modules or specific treatment procedures.
Clinicians delivering MATCH-ADTC follow structured
and specific treatment procedures, as outlined in the
MATCH-ADTC manual. At the start of treatment, a
clinician meets with the youth participant and the
youth’s family and they collaboratively establish top
problems to be addressed in therapy, thus providing
the participant and their family an integral role in de-
fining the goals for therapy. Following this, clinicians
(with the support of a MATCH-ADTC expert) are
guided by an evidence-based algorithm to ensure that
treatment is best tailored to the youth’s clinical presenta-
tion. Each MATCH-ADTC module contains details about
the therapy session, including such resources as therapy
worksheets, homework assignments, and caregiver hand-
outs. Clinicians use a web-based system (the eMonitor, de-
signed purposefully for this trial), which provides a weekly
summary of the participant’s progress (based on the re-
sults of the Brief Problem Monitor and Top Problem
Assessment), to monitor their client’s progress and adapt
therapy in consultation with the youth and the youth’s
family.
Intervention fidelity
MATCH-ADTC therapists have weekly phone or
Skype supervision where treatment for each youth is
reviewed. Clinicians follow the MATCH-ADTC man-
ual with the support of a MATCH-ADTC expert. All
sessions (MATCH-ADTC and usual care) are audio-
recorded and a randomly selected subset will be coded for
evidence-based therapy content.
Control (usual care)
Usual care is the treatment that is usually provided to a
youth at a CAMHS (e.g., case management, individual
therapy, family therapy, medication, psycho-education,
or a combination of these). Information on the usual
care provided to each participant is collected. Clinicians
providing usual care do not have access to the weekly
progress data on the eMonitor, as this is not part of
usual care.
Clinicians providing both MATCH-ADTC and usual
care receive support from their team leaders and clinical
managers, but MATCH-ADTC clinicians are instructed
not to discuss with the rest of their team the treatment
approaches they are using with their MATCH-ADTC cli-
ents, to ensure there is no contamination. This approach
was used successfully in the study in the USA [30].
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Outcomes and measures
Primary outcomes
The three primary outcomes each address one of the
three central aims of the trial: (i) the difference in trajec-
tory of change of clinical severity between groups, using
the parent-rated Brief Problem Monitor [42]; (ii) clini-
cians’ use of evidence-based content during therapy ses-
sions (based on audio-recorded therapy sessions); (iii)
total time spent by clinicians delivering therapy (using
therapy logs).
Secondary outcomes
Other clinical outcomes are measured using: the youth-
rated Brief Problem Monitor [42], the parent- and
youth-rated Strengths and Difficulties Questionnaire
[43], the parent- and youth-rated Top Problems Assess-
ment [44], the youth-rated Child Health Utility [45], the
number and type of diagnoses using the Development
and Well-Being Assessment [46, 47], prescribed medica-
tions (and dosage) for psychiatric conditions.
Further secondary outcomes include:
 Clinician self-report of the treatment provided based
on the Therapy Procedures Checklist [48];
 Clinician’s satisfaction with therapy based on the
Therapist Satisfaction Inventory [49];
 Client satisfaction with therapy based on a
treatment satisfaction questionnaire;
 The number and types of serious adverse events and
moderate adverse events.
Outcome measures
The following outcome measures are collected during the
trial. Most clinical measures are collected during the
weekly telephone calls made by the research assistants ac-
cording to the schedule of assessments listed in Table 1.
The Brief Problem Monitor [42] is a 19-item assessment
using data from parents and youth to measure internaliz-
ing, externalizing, hyperactivity, and total problems. It is
based on the widely used Child Behavior Checklist [50]
and Youth Self-Report [51], both of which have sound
psychometric qualities. The Brief Problem Monitor can be
administered by phone, taking approximately five minutes
to complete per administration, making it a practical and
robust measure of the trajectory of change in clinical
symptoms over time.
 The Top Problems Assessment has been developed
to allow the youth and family to identify and rate
the severity of the three top problems that they
would like addressed in therapy. There is good
evidence for reliability, validity, and sensitivity to
change for this assessment [44].
 The Strengths and Difficulties Questionnaire [43] is
a scale used widely in both research and practice. It
produces a total score with five subscales: emotional
Table 1 Summary schedule of data collected
Measure Baseline During
therapy
After
intervention
3-month
follow-up
Informant Collected by
Demographics × Child and parent Clinician
Strengths and Difficulties
Questionnaire
× monthly × × Child and parent Research assistant
Brief Problem Monitor × weekly × × Child and parent Research assistant
Top Problems Assessment × weekly × × Child and parent Clinician at baseline and
research assistant weekly
Development and
Well-Being Assessment
× × Child (if 11 or over) and parent Research assistant supports the
family to complete online
Child Health Utility × × × Child Research assistant
Medication use × × × Clinician and parent Clinician at baseline and after
intervention, research assistant
at 3 months
Client satisfaction × Child and parent Research assistant
Therapy Procedures Checklist × Clinician Clinician
Serious adverse events × Clinician Clinician
Moderate adverse events × Parent Research assistant
Therapist Satisfaction
Inventory
× Clinician Clinician
Recordings of therapy
sessions
× Clinician Clinician
Therapy log × Clinician Clinician
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symptoms, conduct problems, hyperactivity, peer
relationship problems, and prosocial behavior. It has
a satisfactory internal consistency, test–retest
reliability, and inter-rater agreement [52].
 Child Health Utility [45] is a nine-item measure of
health-related quality of life designed specifically for
children. Each item taps into a different domain (i.e.,
worry, sadness, pain, tiredness, annoyance, school,
sleep, daily routine, and activities) in reference to
how a child feels ‘today’. This is a preference-based
instrument that generates utility weights and which
allows for the calculation of quality-adjusted life years
for use in health economic evaluations. The internal
consistency has been reported sound and the
convergent validity against the Strengths and Difficulties
Questionnaire is in the moderate-to-strong range [53].
 The Development and Well-Being Assessment [46]
is an online diagnostic tool. It is designed to indicate
likely psychiatric diagnoses in 5–16-year-olds based
on in-built diagnostic algorithms. This assessment has
been validated in both community and clinic samples
in the UK [46]. Inter-rater agreements between
the Development and Well-Being Assessment and
clinician diagnoses are moderate to high [54–56].
 Client satisfaction questionnaires. The parent-rated
measure has nine questions (eight-rated on a Likert
scale and one open-ended item). The youth-rated
satisfaction questionnaire includes seven questions
(four rated on a Likert scale and three open-ended
items). Likert-rated questions ask the informant to
provide feedback on the quality of treatment,
whether it helped, and if they would recommend it
to others. The open-ended questions were designed
to elicit what the participants liked most or least
about the treatment and how treatment could be
improved.
 The Therapist Satisfaction Inventory is a 16-item
questionnaire (adapted from [49]), which assesses
how satisfied a clinician feels about the intervention
provided.
 The Therapy Procedures Checklist is a treatment
description questionnaire, which consists of 62 items
describing common psychotherapeutic processes
(i.e., psychodynamic, cognitive, and behavioral
techniques) that may have been used in the course of
therapy. Each item is rated on a five-point Likert scale
from ‘rarely’ to ‘most of the time’. The instrument is
adapted from an earlier version of the Therapy
Procedures Checklist, which has been shown to have
good content validity, internal consistency, and
test–retest reliability [48].
 The medication use questionnaire collects data on
prescribed medications (and dosage) for
psychiatric conditions.
The efficiency of service delivery is assessed using the
therapy log. It includes: (1) the date and duration of each
therapy session (in minutes); (2) whether non-study cli-
nicians were also involved in a session; (3) the location
of a therapy session (e.g., clinic, home, school); and (4)
whether any scheduled sessions were unattended by the
youth and family.
The amount of evidence-based therapy content is based
on digitally recorded therapy sessions (all sessions, both
MATCH-ADTC and usual care). A randomly selected
subset of 10 % of therapy sessions from each arm are
assessed for evidence-based content by the research team
(blind to treatment allocation) based on the methods and
the coding system (Bearman S, Herren J, Weisz J.,
Therapist Integrity to Evidence-Based Interventions,
2012, unpublished manual) developed for the initial
trial of MATCH-ADTC [30]. A subset of this sample
is independently double-coded to confirm inter-rater
agreement. The Therapist Integrity to Evidence-Based
Interventions is a micro-analytic system for coding
therapy sessions for the fidelity (adherence and com-
petence) with which a therapist utilized therapeutic
techniques used in MATCH-ADTC [25]. Scores on this
measure reflect both adherence (frequency and thorough-
ness) and competency (skillfulness). The Therapist Integ-
rity to Evidence-Based Interventions was adapted from a
previous coding system, in order to merge overlapping
items [30]. This version has shown to have excellent levels
of coder agreement for both adherence (multivariate intra-
class correlation coefficient = 0.84) and competence (multi-
variate intraclass correlation coefficient = 0.78) in a sample
of community therapists in the USA delivering both
MATCH-ADTC and usual care [57].
Measures of harm
A serious adverse event is defined as an event that: (1)
results in the participant’s death, (2) is a suicide attempt;
(3) results in hospitalization for non-suicidal self-harm;
or (4) results in hospitalization for mental health prob-
lems. Clinicians are instructed to report serious adverse
events at any stage during therapy within one working
day of being aware of the event. A report of a serious ad-
verse event is followed by a telephone call to the clin-
ician from the research team to collect additional
information on the serious adverse event, in order to de-
termine the relationship to the study, and the appropriate
course of action (continuation or withdrawal from the
trial). All serious adverse events are reviewed by a senior
clinician independent of the study and reported to the in-
dependent data monitoring committee (from the Health
Research Council) and the trial steering committee.
Moderate adverse events are defined as: (1) hospi-
talization for any medical reason, other than mental
health problems; (2) serious behavioral problem (i.e.,
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suspension or expulsion from school, running away from
home, or problems with the police); or, (3) the use of
formal respite care. Information on moderate adverse
events is recorded when reported during the study and
also collected from the parents at follow-up interview.
These events are also reported to the independent data
monitoring committee (from the Health Research Council)
and the trial steering committee.
Assessment process
Screening for eligibility
Young people referred to CAMHS are provided with a
routine assessment by an intake clinician. Potential par-
ticipants who are deemed suitable for treatment at the
service and meet study criteria are then invited to take
part in the study. The assessing clinician obtains consent
or assent from the youth and parent and collects the
demographics data. Those who are eligible and have
given consent are then randomized, and a study site co-
ordinator allocates a clinician to provide therapy accord-
ing to treatment group allocation.
Baseline measurement
Once the clinician has established with the youth and
parent the key problems, using the Top Problems As-
sessment in a face-to-face session, weekly ratings on
these are collected by the research assistant via tele-
phone. Other baseline measures are collected by the re-
search assistant.
Weekly measurements
The allocated research assistant completes the weekly
telephone assessments with the parent and the youth
participant for the duration of treatment. The weekly as-
sessment is designed not to exceed 10 minutes, to
minimize participant burden.
Monthly assessment
Once a month, in addition to the weekly measures, the
research assistant conducts the Strengths and Difficulties
Questionnaire (parent- and youth-rated) assessments.
Post-intervention assessment
The post-intervention assessment occurs once a clinician
has discharged the youth from treatment and is con-
ducted by the research assistant.
Three month follow-up
Three months after the post-intervention assessment, a
final follow-up assessment is conducted by the research
assistant.
Participant flow is outlined in Fig. 1. The study proce-
dures are summarized in Table 1.
Sample size
Overall, a sample size of 60 clinicians and 400 patients
will provide sufficient power to detect effect sizes of ap-
proximately 0.37, well below the effect size shown by the
comparable USA study [30]. The initial power calcula-
tion was to allow independent analysis to be undertaken
for Māori and Pacific participants and ensured sufficient
power (80 %) to detect moderate effect sizes of between
0.61 and 0.70 as statistically significant (two-tailed α =
0.05) in these groups (equivalent to the effect sizes found
in the USA study [30]). This estimate allowed for a 15 %
attrition rate in clinicians and in clients (based on the
12.3 % attrition rate reported in Weisz et al. [30] and ad-
justment for the clustering of patients with clinicians
(intraclass coefficient = 0.1)). We assumed approximately
six to eight patients per clinician (approximately 400 pa-
tients). If fewer clinicians were available within the tar-
geted services, we planned to increase the number of
participants per clinician to ensure that we maintained
statistical power. The intention was to recruit approxi-
mately 12 clinicians working in Kaupapa Māori services
and approximately 12 clinicians working in Pacific ser-
vices. While this seemed feasible in the planning stages,
when we were actually conducting the trial, there were a
number of staffing difficulties in the services overall, and
these impacted more particularly in the Kaupapa Māori
and Pacific services, perhaps because of the smaller pool
of people in the workforce. This led to difficulty in
recruiting clinicians working in Māori and Pacific ser-
vices, with resulting reduced ability to recruit partici-
pants to the trial from those services. It became evident
that we would not reach the targets for Māori and
Pacific participants to allow ethnic-specific analysis, as
planned. An interim blinded-to-treatment allocation,
single group, power analysis was undertaken (when ap-
proximately 50 participants had completed treatment) to
determine the total number of participants needed to
show overall clinical effectiveness for the whole sample.
This summary produced a standard deviation for the
change in the parent-rated Brief Problem Monitor of 4.4,
which indicated that to show a clinically important dif-
ference in the change (>2 units) as statistically significant
(two-tailed α = 0.05) with 80 % power, a total sample size
of 160 participants would need to be recruited. A total
sample of 200 participants would provide 90 % power
for this comparison. Although a reduced final sample
size would compromise the ethnic-specific analysis, it
was felt that the primary question of whether MATCH-
ADTC improved the trajectory of change of clinical
severity more than usual care could be conclusively ad-
dressed with 200 participants. Based on the ongoing re-
cruitment, it was anticipated that this total recruitment
could be achieved if we extended the timeline and re-
cruited until the end of June 2015.
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Randomization and sequence generation
Youth are recruited over many months, and are not all
available for randomization at the outset of the trial,
whereas the clinicians had to be randomized initially so
that those in the MATCH-ADTC condition could all re-
ceive training prior to recruiting youth for the study. We
believe that any possible selection bias has been avoided,
as any youth participant who is randomized can then be
Fig. 1 Participant flow. Note that this is the original flow chart and has been amended to 100 participants per arm with the reduced recruitment
target. As many participants as possible are recruited from Kaupapa Māori and Pacific services. CAMHS, Child and Adolescent Mental Health
Services; EBT, evidence-based treatment; MATCH, Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct; RA,
research assistant; UC, usual care
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immediately allocated to their randomization group. Be-
cause this random allocation was carried out by the
study team, with no input from clinicians or clinic staff,
there was no possibility of the screening or allocation
process being biased by any of the treating clinicians.
The randomization sequences for clinicians and youth
participants were electronically generated in permuted
blocks prior to any recruitment and loaded into the
eMonitor system.
Allocation concealment
Allocation concealment for the participants and re-
searchers has been assured by using centralized com-
puter allocation of the randomization sequence. The
randomization list is not available to any members of
the research team directly involved in the assessment or
screening of participants. A participant is only random-
ized once all entry criteria are met. After the details of a
consenting participant are entered online, the eMonitor
informs the study site coordinator or the clinician of the
randomized group allocation.
Blinding
Owing to the nature of the study, double blinding is not
possible, as clinicians are aware of the treatment they are
administering. We anticipate that despite signing in-
formed consent, most youth and their parents will effect-
ively be blind to treatment allocation. At entry to the
study, the information conveyed to the participants (orally
and in writing) has been designed to ensure that details
that could easily distinguish MATCH-ADTC from usual
care are not provided, but that accurate information is
given. We explain that both treatments are thought to be
effective and that the purpose of this research is to com-
pare treatments to see if one is better than the other. All
research assistants collecting telephone administered as-
sessments and coding the therapy sessions are blind to
treatment allocation throughout the study. Participants
are asked not reveal the details of the intervention they
are receiving to the research assistant. All participants are
given an identification number to ensure that the re-
searchers involved in data management and manipulation
are unaware of the treatment allocation.
Statistical methods
Interim analysis
When recruitment was lower than anticipated, a single
interim blind calculation of the standard deviation of the
change in the primary outcome parent-rated Brief Prob-
lem Monitor for all participants as a single group was
undertaken, to determine the utility of recruiting a
smaller sample size than originally planned. As this sum-
mary did not involve a comparison between randomized
groups, no adjustment to the α level for protection of
the type I error rate was required.
Overall analysis
The comparability of the baseline status of both treat-
ment groups (i.e., MATCH-ADTC and usual care) will
be determined using descriptive analysis, in terms of age,
sex, clinical symptom severity, diagnosis, and ethnicity.
The two randomized treatments may vary in duration, so
that post-intervention and follow-up (three months after
treatment has ended) analyses are potentially confounded
by treatment duration. To allow an unconfounded inter-
pretation, we propose to use the trajectories of change
across time on the parent-rated Brief Problem Monitor as
our primary outcome measure. The trajectory of change
was selected in part because the duration of treatment
and number of sessions provided to individual youth are
variable in usual clinical services, and also within the
structure of the MATCH-ADTC program, such that the
usual care and MATCH-ADTC groups could not be
matched for duration or number of sessions. In addition,
we want to compare the results of the current study with
that of a trial from the USA that used this method [30].
The primary analysis will be based on the intention-to-
treat population, but sensitivity analysis will be undertaken
on the per-protocol population.
Primary outcomes
Clinical outcomes The difference in the trajectories be-
tween groups will be tested using a mixed effects regres-
sion model: a0 (intercept) + a1 (participant) + a2 (treatment
group) + a3 (time) + a4 (treatment × time) and intercept
and participant as random effects. These analyses will fur-
ther include terms for:
 Service type (i.e., Kaupapa Māori, Pacific and
‘mainstream’ CAMHS);
 Clinicians’ previous training in evidence-based
therapy;
 Baseline symptom level; and
 Medication use.
Although we are now unable to conduct ethnic-specific
analysis, summary data will be used to illustrate whether
there is a broad consistency of the clinical outcome results
across ethnicity groups.
Delivery of evidence-based treatments The percentage
of evidence-based content and quality of delivery of ther-
apy in a 10 % random subset of sessions assessed by coding
audio-taped therapy sessions will be compared between
groups using an analysis of variance (ANOVA) model, fol-
lowing the method used in the trial in the USA study [30].
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Efficiency of service delivery Efficiency in delivery of
therapy for MATCH-ADTC and usual care will be com-
pared using ANOVA to test for significant differences
using the following data which will be collected from the
clinical service, including:
 Clinician time (in minutes);
 Duration of contact with the service (in weeks);
 Number of therapy sessions; and
 Number of missed therapy sessions.
If any of these outcomes do not meet the assumptions
for parametric ANOVA models, the data will be trans-
formed as appropriate prior to analysis.
Discussion
This trial has been designed to balance the need to repli-
cate the evaluation of MATCH-ADTC conducted in the
USA with the objective of evaluating it in a New Zealand
context. We anticipate that if results are positive,
MATCH-ADTC may become part of core training for
CAMHS clinicians, resulting in better outcomes for
youth with mental health challenges, increase in delivery
of evidence-based treatments, and improved efficiency
of service delivery. This trial therefore has practical im-
plications for the workforce, as MATCH-ADTC is the
first comprehensive evidence-based system that could
realistically become part of a ‘core competency’ training
package for all CAMHS clinicians.
We selected brief measures to keep the weekly tele-
phone assessments as brief as possible, and lessen partici-
pant burden. Frequent assessments allow for monitoring
of change when treatment duration varies considerably
and the end of treatment is unknown. We have used an
online diagnostic tool because we do not have dedicated
researchers at each site, and because formal diagnoses are
not routinely obtained in each CAMHS in New Zealand.
In return for the time taken to complete the assessment,
and to maximize Development and Well-Being Assess-
ment completion, we have chosen (with ethics committee
approval) to incentivize families with gift vouchers. Each
family received a NZ$30 (approximately US$20) super-
market gift voucher for completing the Development and
Well-Being Assessment at baseline and a second NZ$30
voucher after intervention. Those who completed both
the baseline and the post-intervention Development and
Well-Being Assessment received an additional NZ$30 (in
total NZ$90). These gift vouchers were provided as a gra-
tuity for the time taken to complete these assessments.
Most CAMHS in New Zealand structure their services
using the Choice and Partnership Approach [58], in
which an intake clinician conducts the initial assessment
to determine whether the treatment at CAMHS is suit-
able for the young person, and then a treatment clinician
is allocated and therapy is provided by the allocated clin-
ician. This allows for a screening assessment and for
randomization at the intake session without disrupting
the rapport established between the family and the clin-
ician, as the allocated clinician usually differs from the
intake clinician.
One of the practical challenges for this study is deter-
mining the end of treatment because services have dif-
ferent guidelines in place regarding discharge (e.g., a
case can be left open for a number of weeks after a pro-
posed final session, in case a youth and their family
would like an extra ‘top-up’ session). If needed, the regu-
lar weekly assessments and the therapy log data will
allow us to determine retrospectively when treatment
ended and link this to the correct weekly telephone ad-
ministered assessments. Another issue has been the re-
cruitment of youths at Māori and Pacific sites. The
challenges that impacted on recruitment of these groups
included the smaller pool of clinicians at Kaupapa Māori
and Pacific services, the smaller proportion of youths
meeting study criteria because of high acuity of the
problems (including suicidality) and the lower numbers
of youths within our age range.
This is a pragmatic trial [41] and accordingly the ex-
clusion criteria have been kept to a minimum and youth
participants’ presentation (not their diagnoses) have de-
termined eligibility for participation in the study. As
such, we believe this study will have good external valid-
ity, because the participants reflect the heterogeneity of
youth from ‘real-life’ clinical services. Hence the findings
will be applicable to other CAMHS in New Zealand and
will probably be of relevance to other countries that have
a comparable healthcare workforce and service delivery
models.
Trial status
We are currently recruiting participants.
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